Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Nanofiber Solutions LLC focuses its patent portfolio on the Biotechnology & Pharmaceuticals technology area. The portfolio currently has 2 pending office actions. These matters are being examined within 1 distinct art unit, which suggests a consistent technical focus for the company's current filings. Prosecution involves 2 distinct examiners.
LIPPERT, JOHN WILLIAM is the busiest examiner for the portfolio, currently handling 1 busiest examiner pending action. Although the 2 pending office actions are in 1 distinct art unit, the presence of 2 distinct examiners requires practitioners to adapt to different individual perspectives. The 1 busiest examiner pending action under LIPPERT, JOHN WILLIAM represents a portion of the total workload. Maintaining consistency in technical arguments across the Biotechnology & Pharmaceuticals filings will be important, even as the matters are reviewed by different examiners within the same art unit. Practitioners should monitor the specific requirements of the 2 distinct examiners to ensure that the 2 pending office actions are resolved efficiently.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LIPPERT, JOHN WILLIAM | 1 | 59.2% | +39.9% |
| NGUYEN, NGOC-ANH THI | 1 | 30.3% | +50.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17753890 | NANOFIBER- AND NANOWHISKER-BASED TRANSFECTION PLATFORMS | NGUYEN, NGOC-ANH THI | 9d overdue |
| 18549702 | Nanofiber- and Nanowhisker-Based Transfection Platforms for Bulk Electroporation | LIPPERT, JOHN WILLIAM | 5d overdue |
| Art Unit | Apps |
|---|---|
| 1615 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18549702 | Nanofiber- and Nanowhisker-Based Transfection Platforms for Bulk Electroporation | LIPPERT, JOHN WILLIAM | 1615 | §112 | Final Rejection | 5d overdue | Pending | Sep 08, 2023 |
| 17753890 | NANOFIBER- AND NANOWHISKER-BASED TRANSFECTION PLATFORMS | NGUYEN, NGOC-ANH THI | 1615 | §103 | Final Rejection | 9d overdue | Pending | Mar 17, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNanofiber Solutions LLC has 2 pending office actions as of October 2026, spread across 1 art units and 2 examiners.
John William Lippert has the most, with 1 of Nanofiber Solutions LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
